Paper Details

  1. Home
  2. Paper Details

Investigational drugs currently in phase II clinical trials for actinic keratosis.

Author: BianchiLuca, CampioneElena, DiluvioLaura, GarofaloVirginia, LannaCaterina, LozziFlavia, MazzeoMauro, MazzilliSara, PalumboVincenzo, TerrinoniAlessandro

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Actinic keratoses (AKs), caused by sun damage, require field-directed therapies to prevent recurrence and potential progression to squamous cell carcinoma.
Paper Details　
Original Abstract of the Article :
Actinic keratoses (AKs) are limited areas of irregular epidermal growth on a background of excessive solar exposure. The entire sun-damaged skin is considered a field of cancerization with multiple visible and subclinical lesions. AK management requires field-directed therapies to block lesion relap...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/13543784.2019.1636030

データ提供：米国国立医学図書館（NLM）

Exploring the Landscape of Actinic Keratosis: A Search for Effective Treatments

This review examines the current landscape of investigational drugs in phase II clinical trials for the treatment of actinic keratosis (AK). The researchers, like tireless explorers seeking a cure for this prevalent condition, aimed to assess the promising therapies being developed for AK. This research is like navigating a vast desert of dermatological conditions, seeking to find new oases of hope for those affected by AK.

A New Dawn for Actinic Keratosis Treatment

The review highlights the advancements in AK treatment, showcasing the diverse range of investigational drugs being explored in clinical trials. These findings offer hope for individuals seeking effective and safe options for managing AK and preventing its progression into squamous cell carcinoma (SCC). It's like discovering new springs of hope in the desert of AK management, providing a more comprehensive and effective approach to treating this condition.

Toward Personalized and Effective Treatment Strategies

This review underscores the importance of continued research and development in the field of AK treatment. The findings emphasize the need for personalized and effective treatment strategies, tailored to individual patient needs and risk factors. It's like embracing a diverse range of approaches to navigating the challenging desert of AK, seeking to find the most effective and sustainable solutions.

Dr.Camel's Conclusion

This review provides a glimpse into the exciting landscape of investigational drugs for actinic keratosis, offering hope for individuals seeking effective treatment options. The findings encourage continued research and development in this area, paving the way for more personalized and effective treatment strategies. It's a reminder that the quest for effective solutions in the desert of dermatological conditions is ongoing, and we must continue to explore new oases of hope for those affected by AK.

Date :
  1. Date Completed 2019-07-12
  2. Date Revised 2019-07-12
Further Info :

Pubmed ID

31232099

DOI: Digital Object Identifier

10.1080/13543784.2019.1636030

Related Literature

Article Analysis
・Effects of eflornithine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.